Corrigendum to "Dual Effects of Cellular Immunotherapy in Inhibition of Virus Replication and Prolongation of Survival in HCV-Positive Hepatocellular Carcinoma Patients"

J Immunol Res. 2022 Jul 16:2022:9761463. doi: 10.1155/2022/9761463. eCollection 2022.

Authors

Lei Qian¹, Nanya Wang¹, Huimin Tian¹, Haofan Jin¹, Hengjun Zhao¹, Chao Niu¹, Hua He¹, Tingwen Ge¹, Wei Han¹, Jifan Hu¹, Dan Li¹, Fujun Han¹, Jianting Xu¹, Xiao Ding¹, Jingtao Chen², Wei Li¹, Jiuwei Cui¹

Affiliations

¹ Department of Cancer Center, The First Hospital of Jilin University, Changchun 130021, China.
² Institute of Translational Medicine, The First Hospital of Jilin University, Changchun 130021, China.

Abstract

[This corrects the article DOI: 10.1155/2016/6837241.].

Copyright © 2022 Lei Qian et al.

Publication types

Published Erratum